Product
EGCG
Name
EGCG
4 clinical trials
5 indications
Indication
Multiple System AtrophyIndication
Idiopathic Pulmonary FibrosisIndication
Cervical Intraepithelial NeoplasiaIndication
Interstitial PneumoniaIndication
Neoplasms MalignantClinical trial
Double-blind, Randomised, Placebo-controlled Parallel Group Study to Investigate the Effect of EGCG Supplementation on Disease Progression of Patients With Multiple System Atrophy (MSA)Status: Completed, Estimated PCD: 2016-09-01
Clinical trial
Dose Ranging Study of Oral Epigallocatechin-3-gallate (EGCG) Given Daily for 12 Weeks to Patients With Idiopathic Pulmonary Fibrosis (IPF) Evaluating Safety, PK Interactions With Standard of Care Drugs, and Biomarkers of Drug EffectStatus: Recruiting, Estimated PCD: 2025-03-31
Clinical trial
Treatment With Epigallcoatechin Gallate, Hyaluronic Acid, Folic Acid and Vitamin B12 in Women HPV Positive With Abnormal Cytology TestsStatus: Active (not recruiting), Estimated PCD: 2024-05-15
Clinical trial
Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients: Phase I-II Clinical TrialStatus: Recruiting, Estimated PCD: 2023-12-31